28421738|t|Targeting the Nrf2 / Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach
28421738|a|Amyloid is a prominent feature of Alzheimer's disease (AD). Yet, a linear linkage between amyloid-β peptide (Aβ) and the disease onset and progression has recently been questioned. In this context, the crucial partnership between Aβ and Nrf2 pathways is acquiring paramount importance, offering prospects for deciphering the Aβ -centered disease network. Here, we report on a new class of antiaggregating agents rationally designed to simultaneously activate transcription -based antioxidant responses, whose lead 1 showed interesting properties in a preliminary investigation. Relying on the requirements of Aβ recognition, we identified the catechol derivative 12. In SH-SY5Y neuroblastoma cells, 12 combined remarkable free radical scavenger properties to the ability to trigger the Nrf2 pathway and induce the Nrf2 - dependent defensive gene NQO1 by means of electrophilic activation of the transcriptional response. Moreover, 12 prevented the formation of cytotoxic stable oligomeric intermediates, being significantly more effective, and per se less toxic, than prototype 1. More importantly, as different chemical features were exploited to regulate Nrf2 and Aβ activities, the two pathways could be tuned independently. These findings point to compound 12 and its derivatives as promising tools for investigating the therapeutic potential of the Nrf2 / Aβ cellular network, laying foundation for generating new drug leads to confront AD.
28421738	0	9	Targeting	T044	C1159372
28421738	14	18	Nrf2	T116,T123	C0289507
28421738	21	41	Amyloid-Beta Liaison	T044	C1149161
28421738	45	64	Alzheimer's Disease	T047	C0002395
28421738	68	85	Rational Approach	T081	C0010998
28421738	86	93	Amyloid	T116,T123	C0002716
28421738	99	108	prominent	T080	C0205402
28421738	109	116	feature	T080	C2348519
28421738	120	139	Alzheimer's disease	T047	C0002395
28421738	141	143	AD	T047	C0002395
28421738	153	159	linear	T082	C0205132
28421738	160	167	linkage	T080	C0439849
28421738	176	193	amyloid-β peptide	T116	C0078939
28421738	195	197	Aβ	T116	C0078939
28421738	207	220	disease onset	T079	C0277793
28421738	225	236	progression	T046	C0242656
28421738	275	282	context	T078	C0449255
28421738	296	307	partnership	T080	C0439849
28421738	316	318	Aβ	T044	C1510880
28421738	323	336	Nrf2 pathways	T044	C1518762
28421738	340	349	acquiring	T080	C0439661
28421738	350	359	paramount	T080	C0205250
28421738	360	370	importance	T080	C3898777
28421738	395	406	deciphering	T169	C1285553
28421738	411	413	Aβ	T116	C0078939
28421738	424	431	disease	T047	C0012634
28421738	432	439	network	T169	C1882071
28421738	462	465	new	T080	C0205314
28421738	475	497	antiaggregating agents	T121	C0085826
28421738	521	535	simultaneously	T079	C0521115
28421738	536	558	activate transcription	T045	C0162493
28421738	566	577	antioxidant	T121	C0003402
28421738	578	587	responses	T040	C0683154
28421738	595	601	lead 1	T121	C1254351
28421738	621	631	properties	T080	C0871161
28421738	637	648	preliminary	T079	C0439611
28421738	679	691	requirements	T033	C0556043
28421738	695	697	Aβ	T116	C0078939
28421738	698	709	recognition	T044	C0599844
28421738	714	724	identified	T080	C0205396
28421738	729	751	catechol derivative 12	T121	C1254351
28421738	756	783	SH-SY5Y neuroblastoma cells	UnknownType	C0815000
28421738	785	787	12	T121	C1254351
28421738	788	796	combined	T080	C0205195
28421738	808	830	free radical scavenger	T120	C0079381
28421738	831	841	properties	T080	C0871161
28421738	860	867	trigger	T080	C1444748
28421738	872	884	Nrf2 pathway	T044	C1518762
28421738	889	895	induce	T045	C0017391
28421738	900	904	Nrf2	T116,T123	C0289507
28421738	907	916	dependent	T169	C3244310
28421738	917	926	defensive	T033	C2164680
28421738	927	936	gene NQO1	T028	C0919428
28421738	949	973	electrophilic activation	T070	C1254365
28421738	981	1005	transcriptional response	T045	C0040649
28421738	1034	1043	formation	T169	C1522492
28421738	1047	1056	cytotoxic	T169	C1511636
28421738	1057	1063	stable	T080	C0205360
28421738	1064	1088	oligomeric intermediates	T121	C1254351
28421738	1096	1109	significantly	T078	C0750502
28421738	1110	1114	more	T081	C0205172
28421738	1115	1124	effective	T080	C1704419
28421738	1137	1147	less toxic	T037	C0013221
28421738	1154	1165	prototype 1	T121	C1254351
28421738	1188	1197	different	T080	C1705242
28421738	1198	1215	chemical features	T070	C0243178
28421738	1234	1247	regulate Nrf2	T045	C1523114
28421738	1252	1254	Aβ	T116	C0078939
28421738	1255	1265	activities	T044	C1148560
28421738	1275	1283	pathways	T044	C1704259
28421738	1338	1349	compound 12	T121	C1254351
28421738	1358	1369	derivatives	T121	C1254351
28421738	1411	1422	therapeutic	T169	C0302350
28421738	1423	1432	potential	T080	C3245505
28421738	1440	1444	Nrf2	T116,T123	C0289507
28421738	1447	1449	Aβ	T116	C0078939
28421738	1450	1458	cellular	T025	C0007634
28421738	1459	1466	network	T169	C1882071
28421738	1490	1500	generating	T052	C3146294
28421738	1505	1515	drug leads	T121	C1254351
28421738	1528	1530	AD	T047	C0002395